Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis.

Tytuł:
Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis.
Autorzy:
Choi UY; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.
Lee JJ; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.
Park A; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.
Zhu W; Department of NanoEngineering, University of California San Diego, La Jolla, CA 92093.
Lee HR; Department of Biotechnology and Bioinformatics, College of Science and Technology, Korea University, 30019 Sejong, South Korea.
Choi YJ; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.
Yoo JS; Department of Immunology, Faculty of Medicine, Hokkaido University, 060-8638 Sapporo, Japan.
Yu C; Department of NanoEngineering, University of California San Diego, La Jolla, CA 92093.
Feng P; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.; Section of Infection and Immunity, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA 90089.
Gao SJ; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033.; University of Pittsburgh Medical Center (UPMC), Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219.; Laboratory of Human Virology and Oncology, Shantou University Medical College, 515041 Shantou, Guangdong, China.
Chen S; Department of NanoEngineering, University of California San Diego, La Jolla, CA 92093.
Eoh H; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033; .
Jung JU; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033; .
Źródło:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Apr 07; Vol. 117 (14), pp. 8083-8093. Date of Electronic Publication: 2020 Mar 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Washington, DC : National Academy of Sciences
MeSH Terms:
Cell Transformation, Neoplastic/*pathology
Herpesvirus 8, Human/*metabolism
Proline/*metabolism
Pyrroline Carboxylate Reductases/*metabolism
Sarcoma, Kaposi/*pathology
Viral Proteins/*metabolism
Animals ; Cell Culture Techniques/methods ; Cell Line, Tumor ; Cell Proliferation ; Humans ; Metabolomics ; Mice ; Proline Oxidase/metabolism ; Sarcoma, Kaposi/virology ; Spheroids, Cellular ; Xenograft Model Antitumor Assays ; delta-1-Pyrroline-5-Carboxylate Reductase
References:
J Cell Biochem. 2009 Jul 1;107(4):759-68. (PMID: 19415679)
Science. 2012 May 25;336(6084):1040-4. (PMID: 22628656)
Cell. 2002 Oct 4;111(1):29-40. (PMID: 12372298)
J Clin Invest. 2012 Mar;122(3):1076-81. (PMID: 22293176)
J Virol. 2008 Jul;82(13):6514-23. (PMID: 18434405)
Biochem Biophys Res Commun. 2013 Jun 28;436(2):289-94. (PMID: 23743200)
Breast Cancer Res Treat. 2008 Jul;110(2):297-307. (PMID: 17879159)
Biochemistry. 2018 Jun 26;57(25):3433-3444. (PMID: 29648801)
Nat Commun. 2017 Jul 07;8:16031. (PMID: 28685754)
Amino Acids. 2008 Nov;35(4):691-702. (PMID: 18330497)
J Virol. 2004 Feb;78(4):1918-27. (PMID: 14747556)
Cell Host Microbe. 2011 Dec 15;10(6):577-90. (PMID: 22177562)
Front Pharmacol. 2018 Jan 23;9:6. (PMID: 29410625)
Biotechnol J. 2008 Oct;3(9-10):1172-84. (PMID: 18566957)
Sci Rep. 2015 Nov 24;5:17206. (PMID: 26598224)
Biomaterials. 2017 Apr;124:106-115. (PMID: 28192772)
Nat Commun. 2017 May 11;8:15267. (PMID: 28492237)
Nat Commun. 2014;5:3128. (PMID: 24451681)
Nat Commun. 2019 Feb 19;10(1):845. (PMID: 30783087)
PLoS Pathog. 2015 Jul 21;11(7):e1005052. (PMID: 26197457)
Rev Med Virol. 2015 Sep;25(5):273-85. (PMID: 26192396)
Cell Metab. 2016 Mar 8;23(3):517-28. (PMID: 26853747)
Nature. 2016 Feb 25;530(7591):490-4. (PMID: 26878238)
J Cell Sci. 2017 Jan 1;130(1):203-218. (PMID: 27663511)
Methods. 2003 Jul;30(3):256-68. (PMID: 12798140)
Free Radic Biol Med. 2008 Feb 15;44(4):671-81. (PMID: 18036351)
Dis Model Mech. 2018 Aug 7;11(8):. (PMID: 30104199)
Cell Metab. 2016 Nov 8;24(5):753-761. (PMID: 27618686)
PLoS Pathog. 2012;8(8):e1002866. (PMID: 22916018)
Oncogene. 2006 Sep 14;25(41):5640-7. (PMID: 16619034)
Oncotarget. 2014 May 30;5(10):2962-73. (PMID: 24930674)
J Exp Med. 2000 Jul 3;192(1):11-21. (PMID: 10880522)
Clin Cancer Res. 2018 Jan 15;24(2):474-485. (PMID: 29084919)
Sci Rep. 2016 Jan 06;6:18846. (PMID: 26733354)
Cancer Discov. 2012 May;2(5):401-4. (PMID: 22588877)
Nat Med. 1998 Apr;4(4):435-40. (PMID: 9546789)
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8983-8. (PMID: 22615405)
PLoS One. 2017 Sep 21;12(9):e0185206. (PMID: 28934309)
Cancer Res. 2006 Apr 1;66(7):3658-66. (PMID: 16585191)
PLoS Pathog. 2017 Jan 23;13(1):e1006158. (PMID: 28114403)
Oncogene. 2016 Sep 22;35(38):4957-72. (PMID: 27109103)
Nature. 1997 Sep 18;389(6648):300-5. (PMID: 9305847)
Cancer Res. 2004 Apr 15;64(8):2774-81. (PMID: 15087393)
Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45. (PMID: 17684528)
PLoS Pathog. 2016 Nov 9;12(11):e1005985. (PMID: 27829024)
Cell Res. 2015 Apr;25(4):429-44. (PMID: 25793315)
Antioxid Redox Signal. 2013 Sep 20;19(9):998-1011. (PMID: 23581681)
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10696-701. (PMID: 20498071)
J Nutr. 2008 Oct;138(10):2008S-2015S. (PMID: 18806116)
Carcinogenesis. 2017 May 1;38(5):519-531. (PMID: 28379297)
Cell Host Microbe. 2014 Mar 12;15(3):266-82. (PMID: 24629334)
Adv Dent Res. 2006 Apr 01;19(1):91-5. (PMID: 16672557)
Sci Signal. 2013 Apr 02;6(269):pl1. (PMID: 23550210)
PLoS Pathog. 2016 May 17;12(5):e1005648. (PMID: 27187079)
J Virol. 2003 Jul;77(14):8072-86. (PMID: 12829846)
Nat Rev Cancer. 2001 Oct;1(1):46-54. (PMID: 11900251)
J Virol. 1999 May;73(5):4156-70. (PMID: 10196312)
PLoS Pathog. 2018 Jan 19;14(1):e1006844. (PMID: 29352292)
J Virol. 2006 Aug;80(16):7965-75. (PMID: 16873253)
J Natl Cancer Inst Monogr. 2001;(28):15-23. (PMID: 11158202)
J Virol. 2005 Oct;79(19):12173-84. (PMID: 16160144)
Grant Information:
R01 CA197153 United States CA NCI NIH HHS; R21 AI129496 United States AI NIAID NIH HHS; R01 AI116585 United States AI NIAID NIH HHS; R21 DE027888 United States DE NIDCR NIH HHS; R01 CA221521 United States CA NCI NIH HHS; R01 DE025465 United States DE NIDCR NIH HHS; R01 AI140718 United States AI NIAID NIH HHS; R21 AR074763 United States AR NIAMS NIH HHS; R01 DE023926 United States DE NIDCR NIH HHS; R01 AI073099 United States AI NIAID NIH HHS; R01 CA134241 United States CA NCI NIH HHS; R35 CA200422 United States CA NCI NIH HHS; R01 EB021857 United States EB NIBIB NIH HHS; R01 DE028521 United States DE NIDCR NIH HHS; R35 DE027556 United States DE NIDCR NIH HHS; R01 AI140705 United States AI NIAID NIH HHS
Contributed Indexing:
Keywords: K1; Kaposi's sarcoma-associated herpesvirus (KSHV); cancer metabolism; proline metabolism; pyrroline-5-carboxylate reductase (PYCR)
Substance Nomenclature:
0 (K1 protein, Human herpesvirus 8)
0 (Viral Proteins)
9DLQ4CIU6V (Proline)
EC 1.5.1.- (Pyrroline Carboxylate Reductases)
EC 1.5.3.- (Proline Oxidase)
EC 1.5.5.2 (PRODH protein, human)
Entry Date(s):
Date Created: 20200328 Date Completed: 20200720 Latest Revision: 20231213
Update Code:
20240105
PubMed Central ID:
PMC7149499
DOI:
10.1073/pnas.1918607117
PMID:
32213586
Czasopismo naukowe
Three-dimensional (3D) cell culture is well documented to regain intrinsic metabolic properties and to better mimic the in vivo situation than two-dimensional (2D) cell culture. Particularly, proline metabolism is critical for tumorigenesis since pyrroline-5-carboxylate (P5C) reductase (PYCR/P5CR) is highly expressed in various tumors and its enzymatic activity is essential for in vitro 3D tumor cell growth and in vivo tumorigenesis. PYCR converts the P5C intermediate to proline as a biosynthesis pathway, whereas proline dehydrogenase (PRODH) breaks down proline to P5C as a degradation pathway. Intriguingly, expressions of proline biosynthesis PYCR gene and proline degradation PRODH gene are up-regulated directly by c-Myc oncoprotein and p53 tumor suppressor, respectively, suggesting that the proline-P5C metabolic axis is a key checkpoint for tumor cell growth. Here, we report a metabolic reprogramming of 3D tumor cell growth by oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV), an etiological agent of Kaposi's sarcoma and primary effusion lymphoma. Metabolomic analyses revealed that KSHV infection increased nonessential amino acid metabolites, specifically proline, in 3D culture, not in 2D culture. Strikingly, the KSHV K1 oncoprotein interacted with and activated PYCR enzyme, increasing intracellular proline concentration. Consequently, the K1-PYCR interaction promoted tumor cell growth in 3D spheroid culture and tumorigenesis in nude mice. In contrast, depletion of PYCR expression markedly abrogated K1-induced tumor cell growth in 3D culture, not in 2D culture. This study demonstrates that an increase of proline biosynthesis induced by K1-PYCR interaction is critical for KSHV-mediated transformation in in vitro 3D culture condition and in vivo tumorigenesis.
Competing Interests: Competing interest statement: J.U.J. is a scientific advisor of Vaccine Stabilization Institute, a California corporation.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies